218 related articles for article (PubMed ID: 33726754)
1. Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation.
Wu Y; Gao J; Liu X
Cancer Cell Int; 2021 Mar; 21(1):171. PubMed ID: 33726754
[TBL] [Abstract][Full Text] [Related]
2. Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension.
Zhou W; Liu K; Zeng L; He J; Gao X; Gu X; Chen X; Jing Li J; Wang M; Wu D; Cai Z; Claesson-Welsh L; Ju R; Wang J; Zhang F; Chen Y
Circulation; 2022 Dec; 146(24):1855-1881. PubMed ID: 36384284
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL4-αvβ3 interaction counteracts hypoxia-induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2.
Gomez Perdiguero E; Liabotis-Fontugne A; Durand M; Faye C; Ricard-Blum S; Simonutti M; Augustin S; Robb BM; Paques M; Valenzuela DM; Murphy AJ; Yancopoulos GD; Thurston G; Galaup A; Monnot C; Germain S
J Pathol; 2016 Dec; 240(4):461-471. PubMed ID: 27577973
[TBL] [Abstract][Full Text] [Related]
4. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.
Li X; Padhan N; Sjöström EO; Roche FP; Testini C; Honkura N; Sáinz-Jaspeado M; Gordon E; Bentley K; Philippides A; Tolmachev V; Dejana E; Stan RV; Vestweber D; Ballmer-Hofer K; Betsholtz C; Pietras K; Jansson L; Claesson-Welsh L
Nat Commun; 2016 Mar; 7():11017. PubMed ID: 27005951
[TBL] [Abstract][Full Text] [Related]
5. Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction.
Li X; Redfors B; Sáinz-Jaspeado M; Shi S; Martinsson P; Padhan N; Scharin Täng M; Borén J; Levin M; Claesson-Welsh L
Front Physiol; 2020; 11():763. PubMed ID: 32733273
[TBL] [Abstract][Full Text] [Related]
6. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.
Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke.
Bouleti C; Mathivet T; Coqueran B; Serfaty JM; Lesage M; Berland E; Ardidie-Robouant C; Kauffenstein G; Henrion D; Lapergue B; Mazighi M; Duyckaerts C; Thurston G; Valenzuela DM; Murphy AJ; Yancopoulos GD; Monnot C; Margaill I; Germain S
Eur Heart J; 2013 Dec; 34(47):3657-68. PubMed ID: 23674618
[TBL] [Abstract][Full Text] [Related]
8. ANGPTL4 regulates ovarian cancer progression by activating the ERK1/2 pathway.
Xu J; Wu F; Zhu Y; Wu T; Cao T; Gao W; Liu M; Qian W; Feng G; Xi X; Hou S
Cancer Cell Int; 2024 Feb; 24(1):54. PubMed ID: 38311733
[TBL] [Abstract][Full Text] [Related]
9. Activation of Vascular Endothelial Growth Factor (VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch.
Tian Y; Gawlak G; O'Donnell JJ; Birukova AA; Birukov KG
J Biol Chem; 2016 May; 291(19):10032-45. PubMed ID: 26884340
[TBL] [Abstract][Full Text] [Related]
10. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4.
Galaup A; Gomez E; Souktani R; Durand M; Cazes A; Monnot C; Teillon J; Le Jan S; Bouleti C; Briois G; Philippe J; Pons S; Martin V; Assaly R; Bonnin P; Ratajczak P; Janin A; Thurston G; Valenzuela DM; Murphy AJ; Yancopoulos GD; Tissier R; Berdeaux A; Ghaleh B; Germain S
Circulation; 2012 Jan; 125(1):140-9. PubMed ID: 22086875
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
Zhu X; Guo X; Wu S; Wei L
Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
[TBL] [Abstract][Full Text] [Related]
12. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma.
Abdulkhalek S; Geen OD; Brodhagen L; Haxho F; Alghamdi F; Allison S; Simmons DJ; O'Shea LK; Neufeld RJ; Szewczuk MR
Clin Transl Med; 2014 Dec; 3(1):28. PubMed ID: 26932374
[TBL] [Abstract][Full Text] [Related]
14. FBXW7 inhibits invasion, migration and angiogenesis in ovarian cancer cells by suppressing VEGF expression through inactivation of β-catenin signaling.
Zhong L; Pan Y; Shen J
Exp Ther Med; 2021 May; 21(5):514. PubMed ID: 33791023
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-like 4-Induced 3D Capillary Morphogenesis Correlates to Stabilization of Endothelial Adherens Junctions and Restriction of VEGF-Induced Sprouting.
Liabotis A; Ardidie-Robouant C; Mailly P; Besbes S; Gutierrez C; Atlas Y; Muller L; Germain S; Monnot C
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203415
[TBL] [Abstract][Full Text] [Related]
16. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
17. Programmed death ligand-1 regulates angiogenesis and metastasis by participating in the c-JUN/VEGFR2 signaling axis in ovarian cancer.
Yang Y; Xia L; Wu Y; Zhou H; Chen X; Li H; Xu M; Qi Z; Wang Z; Sun H; Cheng X
Cancer Commun (Lond); 2021 Jun; 41(6):511-527. PubMed ID: 33939321
[TBL] [Abstract][Full Text] [Related]
18. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
19. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
[TBL] [Abstract][Full Text] [Related]
20. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway.
Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D
Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
